Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
WuXi XDC Cayman, Inc. ( (HK:2268) ) has issued an announcement.
WuXi XDC Cayman Inc. has announced a delay in sending a shareholder circular related to previously announced offers to acquire offer shares and cancel share options, transactions that have already been approved by written consent from controlling shareholder WuXi Biologics under Hong Kong listing rules. The company has obtained a waiver from the Stock Exchange allowing it to postpone the despatch of the circular from the original 4 February 2026 deadline to on or before 13 February 2026, with the exchange reserving the right to change or withdraw the waiver if circumstances change, a development relevant for shareholders and potential investors tracking the timeline and regulatory status of the offers.
The most recent analyst rating on (HK:2268) stock is a Hold with a HK$65.00 price target. To see the full list of analyst forecasts on WuXi XDC Cayman, Inc. stock, see the HK:2268 Stock Forecast page.
More about WuXi XDC Cayman, Inc.
WuXi XDC Cayman Inc. is a Cayman Islands–incorporated company listed on the Hong Kong Stock Exchange, with WuXi Biologics (Cayman) Inc. as its controlling shareholder holding more than 50% of its issued share capital. The company is governed by a board comprising executive, non-executive and independent non-executive directors and operates within the regulatory framework of the Hong Kong listing regime.
Average Trading Volume: 4,317,151
Technical Sentiment Signal: Buy
Current Market Cap: HK$75.61B
See more data about 2268 stock on TipRanks’ Stock Analysis page.